Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Viewpoint
Nature Reviews Endocrinology 3, 438–439 (1 June 2007) | doi:10.1038/ncpendmet0510
Ovulation induction in women with polycystic ovary syndrome
Abstract
Anovulatory infertility is a major problem associated with polycystic ovary syndrome; however, several treatment options are now available to induce ovulation in affected individuals. The pros and cons of these medications, which include clomifene citrate, follicle-stimulating hormone, insulin-sensitizing agents, and aromatase inhibitors, are discussed in this Viewpoint.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
